Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This is it...

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Sep 27, 2024 11:09am

93 Views

Post# 36244056

RE:RE:RE:This is it...

I agree, not a stand alone news release saying "we've submitted pre-BTD" but part of an overall update. I hope you're right.

rhodiumd wrote:
Based on a previous post referring to an emai exchangel with MP confirming they’re on track for pre-BTD this month, I suspect they’ll provide an update soon. With management recently granting themselves 12.5 million options, they can’t afford to miss another deadline.

Announcing pre-BTD is crucial to reducing future dilution and attracting major investors, signaling tangible progress beyond just waiting for CR numbers and adding a few more patients to the study.

While pre-BTD is an "unofficial" milestone, it’s significant for TLT. I expect an update for shareholders within the next two weeks.